DENTSPLY SIRONA (NASDAQ:XRAY) Shares Down 3.6% - Here's What Happened

Key Points

• DENTSPLY SIRONA shares fell 3.6% to about $9.77, with trading volume roughly 91% below the average daily level.
• Analyst sentiment remains mixed but centered on “Hold”; MarketBeat reports an average price target of $13.31, while BMO Capital Markets lowered its target to $10 and Barclays maintained an underweight rating.
• The company exceeded quarterly earnings expectations with $0.52 EPS versus a $0.35 consensus and revenue of $898 million, though revenue declined 4.1% year over year and net margin remained negative.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) was down 3.6% during mid-day trading on Thursday . The stock traded as low as $9.93 and last traded at $9.7740. Approximately 460,905 shares were traded during trading, a decline of 91% from the average daily volume of 4,852,365 shares. The stock had previously closed at $10.14.

Analyst Ratings Changes

XRAY has been the topic of several analyst reports. Piper Sandler boosted their price objective on DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 29th. Barrington Research set a $15.00 price target on DENTSPLY SIRONA in a research report on Monday, August 10th. BMO Capital Markets cut their price objective on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a "market perform" rating on the stock in a research report on Thursday. Weiss Ratings reissued a "sell (e+)" rating on shares of DENTSPLY SIRONA in a research note on Monday, August 3rd. Finally, Barclays raised their target price on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an "underweight" rating in a report on Monday, August 24th. Three research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $13.31.

DENTSPLY SIRONA Trading Down 3.8%

The stock has a market capitalization of $1.94 billion, a P/E ratio of -3.55, a PEG ratio of 1.25 and a beta of 0.84. The stock's fifty day moving average price is $12.01 and its 200 day moving average price is $11.54. The company has a debt-to-equity ratio of 1.48, a current ratio of 1.63 and a quick ratio of 1.07.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.35 by $0.17. The business had revenue of $898.00 million for the quarter, compared to analyst estimates of $889.93 million. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The company's quarterly revenue was down 4.1% compared to the same quarter last year. During the same period last year, the company posted $0.52 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Research analysts forecast that DENTSPLY SIRONA Inc. will post 1.4 earnings per share for the current year.

Hedge Funds Weigh In On DENTSPLY SIRONA

Hedge funds and other institutional investors have recently modified their holdings of the business. Tidal Investments LLC increased its holdings in shares of DENTSPLY SIRONA by 13.1% in the 2nd quarter. Tidal Investments LLC now owns 371,967 shares of the medical instruments supplier's stock valued at $3,947,000 after acquiring an additional 43,025 shares during the period. Engineers Gate Manager LP lifted its stake in shares of DENTSPLY SIRONA by 451.5% during the 2nd quarter. Engineers Gate Manager LP now owns 124,810 shares of the medical instruments supplier's stock worth $1,324,000 after purchasing an additional 102,179 shares during the last quarter. Integrated Wealth Concepts LLC bought a new stake in DENTSPLY SIRONA during the second quarter valued at about $791,000. Allworth Financial LP grew its stake in DENTSPLY SIRONA by 163.8% in the second quarter. Allworth Financial LP now owns 4,815 shares of the medical instruments supplier's stock valued at $51,000 after purchasing an additional 2,990 shares during the last quarter. Finally, Nykredit A S bought a new position in DENTSPLY SIRONA in the second quarter worth about $38,000. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental laboratories, and other oral health professionals with solutions spanning preventive, restorative, endodontic, orthodontic, implant, and prosthetic dentistry.

Its portfolio includes dental consumables, equipment and treatment centers, imaging systems, CAD/CAM systems, instruments, dental materials, implants, orthodontic products, and software and digital workflow solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.